WHO
REGULATORY UPDATE
New prequalification listing of a TB NAT assay
Published: 6/19/2026Detected: 4/22/2026
Summary preview
Adds Roche Diagnostics’ cobas® MTB test to the WHO Prequalification list, enabling countries and procurement agencies to select a quality-assured molecular TB diagnostic for scaled-up TB diagnosis and care.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountinfectious_disease
respiratory
manufacturing
quality
clinical
safety
labeling
#WHO prequalification
#TB NAT assay
#molecular tuberculosis diagnostics
#IVD
Official Source Document Source Verified
Access the original document directly from WHO.
More from WHO
- New Deadline for Submission: Request for Quotations (RFQ) from interested Notified Bodies - WHO Prequalification Assessment for Medical Devices10/2/2026
- PQT/AMD newsletter - Q3 2026, Issue 54 is now available10/2/2026
- PQ Webinar: Launch of WHO Prequalification of Medical Devices10/2/2026
- New EUL listing10/2/2026
- Prequalification of In Vitro Diagnostics: Scope Expansion10/2/2026